Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?-Reference-Cited by-同舟云学术

Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?

Published:2021-04-30 Issue:8 Volume:81 Page:881-893
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Updike Wendy H.,Pane Olivia,Franks Rachel,Saber Faizah,Abdeen Farah,Balazy Derek D.,Carris Nicholas W.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-021-01525-x.pdf

Reference43 articles.

1. World Health Organization. Obesity and overweight. In: WHO. Fact sheets. 2020. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 29 Sep 2020.

2. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.

3. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics: 2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139-596.

4. Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37(4):922–33.

5. Ely EK, Gruss SM, Luman ET, Gregg EW, Ali MK, Nhim K, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s National Diabetes Prevention Program. Diabetes Care. 2017;40(10):1331–41.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel nomogram for predicting optimal weight loss response following diet and exercise intervention in patients with obesity;Scientific Reports;2024-08-06

2. Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study;World Journal of Gastroenterology;2024-07-14

3. Discontinuing semaglutide after weight loss: strategy for weight maintenance and a possible new side effect;Canadian Journal of Physiology and Pharmacology;2024-06-01

4. Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis;Scientific Reports;2024-04-25

5. A novel nomogram for predicting successful weight loss following diet and exercise intervention in people with obesity;2024-01-03